Cara Therapeutics Inc. (CARA)

4.94

-0.13 (-2.56%)

At close: Apr 01, 2025, 3:31 PM

4.93

-0.20%

After-hours: Apr 01, 2025, 06:43 PM EDT

Cara Therapeutics Cash Flow Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Net Income	-70.87M	-118.51M	-85.47M	-88.44M	8.41M
Depreciation & Amortization	192K	259K	248K	248K	209K
Stock-Based Compensation	8.93M	13.73M	17.73M	20.79M	14.84M
Other Working Capital	n/a	6.89M	-15.54M	7.85M	-26.84M
Other Non-Cash Items	829K	2.28M	1.69M	1.31M	806K
Deferred Income Tax	n/a	n/a	n/a	752K	-118K
Change in Working Capital	n/a	10.17M	-12.92M	5.26M	-29.63M
Operating Cash Flow	-60.92M	-92.08M	-78.73M	-60.09M	-5.49M
Capital Expenditures	-1.05M	-2.38M	-43K	-39K	-349K
Acquisitions	n/a	n/a	752K	70K	-118K
Purchase of Investments	-32.21M	-113.61M	-95.69M	-208.79M	-232.88M
Sales Maturities Of Investments	81.46M	159.44M	224.44M	204.01M	212.96M
Other Investing Acitivies	543K	n/a	-752K	-4.71M	118K
Investing Cash Flow	48.74M	43.46M	128.71M	-4.75M	-20.27M
Debt Repayment	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-3.6M	37.03M	311K	1.64M	691K
Financial Cash Flow	-3.6M	38.15M	311K	46.61M	39.14M
Net Cash Flow	-15.78M	-10.47M	50.29M	-18.23M	13.38M
Free Cash Flow	-61.96M	-94.45M	-78.77M	-60.13M	-5.84M